ZFIN ID: ZDB-PUB-180315-8
TGF-ß Regulates Cathepsin Activation during Normal and Pathogenic Development
Flanagan-Steet, H., Christian, C., Lu, P.N., Aarnio-Peterson, M., Sanman, L., Archer-Hartmann, S., Azadi, P., Bogyo, M., Steet, R.A.
Date: 2018
Source: Cell Reports   22: 2964-2977 (Journal)
Registered Authors: Flanagan-Steet, Heather, Lu, Po-Nien, Steet, Richard
Keywords: activity-based profiling, cartilage, cathepsin proteases, glycosaminoglycans, glycosylation, lysosomes, mucolipidosis, zebrafish
MeSH Terms:
  • Animals
  • Cathepsins/metabolism*
  • Disease Models, Animal
  • Transforming Growth Factor beta/metabolism*
  • Zebrafish
PubMed: 29539424 Full text @ Cell Rep.
FIGURES
ABSTRACT
Cysteine cathepsins play roles during development and disease beyond their function in lysosomal protein turnover. Here, we leverage a fluorescent activity-based probe (ABP), BMV109, to track cysteine cathepsins in normal and diseased zebrafish embryos. Using this probe in a model of mucolipidosis II, we show that loss of carbohydrate-dependent lysosomal sorting alters the activity of several cathepsin proteases. The data support a pathogenic mechanism where TGF-ß signals enhance the proteolytic processing of pro-Ctsk by modulating the expression of chondroitin 4-sulfate (C4-S). In MLII, elevated C4-S corresponds with TGF-ß-mediated increases in chst11 expression. Inhibiting chst11 impairs the proteolytic activation of Ctsk and alleviates the MLII phenotypes. These findings uncover a regulatory loop between TGF-ß signaling and Ctsk activation that is altered in the context of lysosomal disease. This work highlights the power of ABPs to identify mechanisms underlying pathogenic development in living animals.
ADDITIONAL INFORMATION